The International Multiple Sclerosis Management Practice Announces Major Expansion Plans to NYC Headquarters

Lease for Additional 48,000 Square Feet Makes MS Research and Treatment Center Largest in the World

NEW YORK, Jan. 19 /PRNewswire-USNewswire/ -- The International Multiple Sclerosis Management Practice (IMSMP), a 34,000 square foot research and treatment center dedicated to MS, today announced that it has signed a lease for an additional 48,000 square feet.  This makes it the largest establishment in the world committed to discovering the cause and cure for MS.

The practice expansion will include a Wellness Center and two MRI machines, while the Research Center will expand to include a Stem Cell Research Complex and Experimental Disease Model Facility. Dr. Saud A. Sadiq serves as the IMSMP's Director.  Under his vision, researchers and clinicians work side by side translating bench research into the best clinical care in the world.

"In light of the limited leasing activity experienced in 2009, the consummation of this lease represents one of the more notable leasing transactions for the year," said Scott Vetri, currently a partner at Katten, Muchin, Rosenman, LLP.

"Our ability to make such a bold move in these times of economic uncertainty is a testament to our fundraising, deep philanthropic appreciation, and our drive to care and cure our valued patients," said Dr. Saud A. Sadiq.

Construction is scheduled to begin July, 2010.  

About the IMSMP & MSRCNY

The International Multiple Sclerosis Management Practice and the Multiple Sclerosis Research Center of New York is a leader in MS healthcare and research.  As a center of excellence, it establishes an unparalleled level of care for individualized, compassionate attention to patients' needs and well-being.  Patients receive in-depth assessments and management plans with on-site physical therapists, social workers and neuropsychologists for cognitive rehabilitation.   Appointments may be scheduled with a naturopathic physician, urologist/urogynecologist, pain specialist or massage therapist.  The on-site infusion suite is open 7 days a week for intravenous medications, and a physician is accessible 24 hours a day/7 days a week.  Patients benefit from the research lab by investigation into the cause of MS, disease mechanisms and treatment discoveries.  As an international MS center, patients throughout the United States and from more than 30 countries on 5 continents rely on and visit the IMSMP for care.  

SOURCE International Multiple Sclerosis Management Practice